Beta-Defensin-2 (HBD-2) Human Synthetic Control Peptide

General information

Beta-Defensin-2 (HBD-2) Human Synthetic Control Peptide
100 µg
Catalog no:

Additional extra details

  • Availability

    Please contact us to check the availability


    Synthetic Human-ß-Defensin-2 (hBD-2): Gly-Ile-Gly-Asp-Pro-Val-Thr-Cys-Leu-Lys-Ser-Gly-Ala-Ile-Cys-His-Pro-Val-Phe-Cys-Pro-Arg-Arg-Tyr-Lys-Gln-Ile-Gly-Thr-Cys-Gly-Leu-Pro-Gly-Thr-Lys-Cys-Cys-Lys-Lys-Pro (MW 4328,2)

    Species reactivity


  • Product presentation

    Synthetic peptide lyophilized from acetic acid

    Product category

    Control Peptide

    Antibody's raised in

    Human, synthetic

  • Antibody's isotype


    Antibody's clone


    Product is supplied as


  • Recommended concentration for use


    Protein concentration


    Positive control


  • Pretreatment


    Tested applications

    Control peptide

    Recommended secondary reagent


  • Storage method

    Store at -20'°C'

    UniProt number

    Go to UniProt/SwissProt


    1. Harder J., Bartels J., Christophers E., and J.-M. Schröder (1997) Antibacterial peptide specific for Gram-negative Bacteria / also effective for Candida albicans. Nature 387; 861ff 2. Hiratsuka T., Nakazato M., Date Y., Ashitani J., Minematsu T, Chino N., and S. Matsukura (1998) Biochem. Biophys. Res. Comm. (Pharmacol.) 249; 943 ff 3. Hoover D.M., Rajashankar K.R., Blumenthal R., Puri A., Oppenheimer J.J., Chertov O., and Lubkowski J. (2000) The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem. 275(42):32911-8 4. Hiratsuka T, Mukae H, Iiboshi H, Ashitani J, Nabeshima K, Minematsu T, Chino N, Ihi T, Kohno S, Nakazato M (2003) Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.Thorax. 58(5):425-30.

  • Tips

    Gentaur products are intended for in vitro research use only. They must not be used for clinical diagnostics and not for in vivo experiments in humans or animals.




    Isotype or positive controls by peptides, antibodies and deactivated samples.human, mouse or other beta β- and alpha α- defensins are expressed by neutrophils ( α- ), lymphocytes and epithelial cells. DEFA DEFB genes defend the host against pathogens. GENTAUR supplies anti-defensins, monclonals, polyclonals antisera and recombinant DEFs or peptides of defensin.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

  • Properties

    Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.